The FDA has cleared a new antibody drug, that targets the omicron variant, for adults and adolescent patients with mild-to-moderate cases.
But late last month the FDA revoked its emergency use authorization for Regeneron’s antibody drug, along with Lilly’s. The two medications had been the the backbone of antibody treatment, and doctors were hard pressed to come up with fallbacks when they didn’t work against omicron.
Alternate therapies, including antiviral pills from Pfizer and Merck, have been in short supply. An antibody drug from GlaxoSmithKline that remains effective against omicron is also scarce.Under the U.S. contract with Lilly, the government will receive about 300,000 treatment courses of the new antibody drug in February and another 300,000 in March.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA delays public meeting for COVID-19 vaccine for children under 5 to review more dataBREAKING: The FDA has delayed a public meeting for a COVID-19 vaccine for children under 5 in order to review more data.
Read more »
FDA delays public meeting for COVID-19 vaccine for children under 5 to review more dataThe FDA has delayed a public meeting for a COVID-19 vaccine for children under 5 in order to review more data.
Read more »
FDA delays public meeting for COVID-19 vaccine for children under 5 to review more dataThe FDA has delayed a public meeting for a COVID-19 vaccine for children under 5 in order to review more data.
Read more »
U.S. to buy 600,000 doses of Eli Lilly COVID treatmentThe U.S. is set to buy 600,000 doses of Eli Lilly’s developmental drug bebtelovimab, an antibody treatment that’s been found to neutralize COVID variants including Omicron.
Read more »
Young kids’ COVID vaccines create approval dilemma for FDATwo doses of Pfizer's vaccine showed mixed results in trials, but the agency is considering approving it anyways in anticipation that a future third shot will provide children with strong immunity.
Read more »